Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Reports Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning.

Sort by


Open-Angle Glaucoma - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Open-Angle Glaucoma - Pipeline Review, H2 2016', provides an overview of the Open-Angle Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with analysis by stage of development, drug target, mecha...
$ 2,000.00 Read More

Dyslipidemia - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Dyslipidemia - Pipeline Review, H2 2016', provides an overview of the Dyslipidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete with analysis by stage of development, drug target, mechanism of action (MoA),...
$ 2,000.00 Read More

African Trypanosomiasis - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘African Trypanosomiasis - Pipeline Review, H2 2016', provides an overview of the African Trypanosomiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for African Trypanosomiasis, complete with analysis by stage of development, drug t...
$ 2,000.00 Read More

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016', provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape. The report provides comprehensive information on the therapeutics under development for Metastatic Adenocarcinoma of The Pancreas, ...
$ 2,000.00 Read More

Thalassemia - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Thalassemia - Pipeline Review, H2 2016', provides an overview of the Thalassemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thalassemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), ro...
$ 2,000.00 Read More

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016', provides an overview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Progressive Multiple Sclero...
$ 2,000.00 Read More

Ocular Pain - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Ocular Pain - Pipeline Review, H2 2016', provides an overview of the Ocular Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), ro...
$ 2,000.00 Read More

Polycystic Ovarian Syndrome - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Polycystic Ovarian Syndrome - Pipeline Review, H2 2016', provides an overview of the Polycystic Ovarian Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polycystic Ovarian Syndrome, complete with analysis by stage of develop...
$ 2,000.00 Read More

Ocular Hypertension - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Ocular Hypertension - Pipeline Review, H2 2016', provides an overview of the Ocular Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mecha...
$ 2,000.00 Read More

Grass Pollen Allergy - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Grass Pollen Allergy - Pipeline Review, H2 2016', provides an overview of the Grass Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Grass Pollen Allergy, complete with analysis by stage of development, drug target, me...
$ 2,000.00 Read More

Fabry Disease - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Fabry Disease - Pipeline Review, H2 2016', provides an overview of the Fabry Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fabry Disease, complete with analysis by stage of development, drug target, mechanism of action (Mo...
$ 2,000.00 Read More

Scar - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Scar - Pipeline Review, H2 2016', provides an overview of the Scar pipeline landscape. The report provides comprehensive information on the therapeutics under development for Scar, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
$ 2,000.00 Read More

BCWorld Pharm Co. Ltd. - Product Pipeline Review - 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘BCWorld Pharm Co. Ltd. - Product Pipeline Review, 2016', provides an overview of the BCWorld Pharm Co. Ltd.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by BCWorld Pharm Co. Ltd., complete with analysis b...
$ 1,500.00 Read More

Burns - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Burns - Pipeline Review, H2 2016', provides an overview of the Burns pipeline landscape. The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administrat...
$ 2,000.00 Read More

Pruritus - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary‘Pruritus - Pipeline Review, H2 2016', provides an overview of the Pruritus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of ad...
$ 2,000.00 Read More
Total 3183 records.